BioCentury | May 26, 2017
Clinical News

CHMP recommends against Helsinn's Adlumiz

...recommended against approval of an MAA from Helsinn Healthcare S.A. (Lugano, Switzerland) for Adlumiz anamorelin (ONO-7643...
...Co. Ltd. (Tokyo:4528), Osaka, Japan Product: Adlumiz anamorelin ( ONO-7643 ) (formerly RC-1291) Business: Endocrine/Metabolic Julian Zhu Anamorelin ONO-7643 Helsinn...
...anamorelin ( ONO-7643 ) (formerly RC-1291) Business: Endocrine/Metabolic Julian Zhu Anamorelin ONO-7643 Helsinn Healthcare S.A. Ono Pharmaceutical Co. Ltd. Ghrelin receptor (GHSR) Adlumiz...
BioCentury | Dec 7, 2015
Clinical News

Anamorelin regulatory update

...EMA accepted for review an MAA from Helsinn for anamorelin to treat anorexia, cachexia or unintended...
...Lugano, Switzerland Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Product: Anamorelin ( ONO-7643 ) (formerly RC-1291...
BioCentury | May 11, 2015
Company News

Helsinn, Mundipharma deal

...including Hong Kong and Macau, to a February deal granting Mundipharma commercialization rights to Helsinn’s anamorelin...
BioCentury | Feb 23, 2015
Company News

Helsinn, Mundipharma deal

...Helsinn granted Mundipharma exclusive rights to commercialize anamorelin in Brazil and “key markets” in the Middle...
BioCentury | Oct 13, 2014
Clinical News

Anamorelin: Phase III data

...in 477 non-small cell lung cancer (NSCLC) patients with cachexia showed that once-daily 100 mg anamorelin...
...of 0.96 kg, p<0.0001). Anamorelin missed the co-primary endpoint of improving handgrip strength vs. placebo. Anamorelin...
...Melbourne, Australia Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Product: Anamorelin ( ONO-7643 ) (formerly RC-1291...
BioCentury | Oct 13, 2014
Clinical News

Anamorelin: Phase III data

...in 477 non-small cell lung cancer (NSCLC) patients with cachexia showed that once-daily 100 mg anamorelin...
...of 0.44 kg, p<0.0001). Anamorelin missed the co-primary endpoint of improving handgrip strength vs. placebo. Anamorelin...
...Melbourne, Australia Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Product: Anamorelin ( ONO-7643 ) (formerly RC-1291...
BioCentury | Aug 21, 2014
Cover Story

Fat chance for cancer cachexia

...S.A. de C.V.; Gruppo Angelini; Ono Pharmaceutical Co. Ltd. (Tokyo:4528); Specialised Therapeutics Australia Pty. Ltd. Anamorelin...
BioCentury | Aug 18, 2014
Company News

Helsinn, Gen Pharmaceuticals deal

...Helsinn granted Gen Pharmaceuticals exclusive rights to anamorelin ( ONO-7643 ) in Turkey. Helsinn will be...
...ONO-7643 ) in Turkey. Helsinn will be responsible for development activities and supply of anamorelin...
BioCentury | Jan 27, 2014
Company News

Angelini, Helsinn sales and marketing update

...Helsinn granted Angelini's CSC Pharmaceuticals Handels GmbH subsidiary exclusive rights to commercialize anamorelin ( ONO-7643...
BioCentury | Nov 18, 2013
Company News

Helsinn, Chugai sales and marketing update

...Helsinn granted Chugai's Chugai Pharma Marketing Ltd. subsidiary commercialization rights to anamorelin ( ONO-7643 ) in...
Items per page:
1 - 10 of 25